drugset / Trial / NCT01649427
Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study was to investigate if Tacrolimus Hexal® has similar pharmacokinetic properties compared to Prograf® in de novo renal transplant patients and whether the comparable exposure resulted in similar renal function.
Timeline
- Start
- 2012-10-17
- Primary completion
- 2015-08-20
- Completion
- 2015-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.5 mg | — |
| Subject | Tacrolimus | Small molecule | 1 mg | — |
| Subject | Tacrolimus | Small molecule | 1.5 mg | — |
| Subject | Tacrolimus Hexal | Unknown | 0.5 mg | — |
| Subject | Tacrolimus Hexal | Unknown | 1 mg | — |
| Subject | Tacrolimus Hexal | Unknown | 1.5 mg | — |
Indications
No indication recorded.